Generics

Originals

Biosimilars 1

Medical devices

Nutraceuticals

Filters

Infliximab manufacturers

1 products found

Filters

Filters

Filters , active

Country of origin : Chile

Clear all

1 products found

infliximab

Vials, injection 100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Chile
GMP approvals
WHO, INVIMA
Unavailable markets
Paraguay , Palestinian Territory
Manufacturer #18571
The company produces and markets ophthalmologic products exclusively but expanded rapidly to other specialties, trying to obtain the position of one of the leaders within the international pharmaceutical industry. The company aspires to have the values of respect, loyalty, integrity, and responsibility, amongst others, prevail in all of its relationships with workers, authorities, competitors, clients, and the community at large.

Manufacturer usually replies in 5 days

Infliximab Manufacturers

Infliximab is usually an injectable drug that is used to treat a variety of diseases, such as psoriatic and rheumatoid arthritis, severe plaque psoriasis for adults, and ankylosing spondylitis. Besides, on rare occasions, Infliximab is applied in Crohn’s disease as well as ulcerative colitis treatment with individuals older than 6. In short, Infliximab is used to treat autoimmune diseases. Infliximab is exclusively given by slow injections in the vein, at intervals of 1.5 and 2 months. Infliximab is usually an expensive drug. It was approved in the US back in 1998.

How does Infliximab work?

This medication works by suppressing inflammation processes through modifications of the immune system. Infliximab prevents TNF alpha from acting, which in turn stops and suppresses the inflammation, which the diseases mentioned above might cause. In addition to suppressed inflammation, there is also a high cut of related symptoms.

Daily Dosage

The daily dosage is determined individually and depends on the severity and the stage of the disease, the condition itself, and the weight of the patient. Usually, there is a testing interval of around four months. If the patient’s body does not respond to treatment with Infliximab after 12-16 weeks, the procedure is usually discontinued. About other important information, we would like to disclose that people who had or have tuberculosis are in a higher risk group and should consult with their doctors or pharmacists before proceeding with Infliximab. Furthermore, this medication has been linked to a possible cause of a rare type of liver lymphoma and bone marrow, both fatal as well as other forms of cancer. This drug might affect the immune system of the patient, so they must have additional discussions with their doctors and pharmacists if they feel vulnerable.

Manufacturers of Infliximab

Infliximab is a niche form of medication. It is not produced by every single pharmaceutical product supplier and manufacturer. It is why a centralized global marketplace like Pipelinepharma is a great tool to have at your disposal. This is available for sale in the B2B market. Thanks to Pipelinepharma, buyers from across the world can get in touch and negotiate with all the listed suppliers of this drug. If your company produces, distributes, or wholesales pharmaceutical products – get in touch with us! We will add you to our list, and you will increase sales.

Side effects

If the patient notices one of the following side effects, they should cease consumption and seek medical attention instantly. With that being said, there are two types of side effects with Infliximab. One type of side effects occurs during or just after the injection and others are long-term or surface after a while has passed. They could be caused by an allergic reaction, overdose, or other factors. Most common side effects include: · Dizziness and nausea · All common signs of allergy (hives, swollen face, fever and chills, breathing complications) · Skin changes (from color to durability, to growths) · Liver issues · Issues with the nervous system (tingling, numbness, etc.) · Coughs and stuffy nose · Headaches Please keep in mind that only some of the common and not all side effects were listed.

The Wholesale Price of Infliximab

The wholesale price of the injectable forms of Infliximab are quite high. In the United States, for example, the cost of months’ treatment could be as high as 19 thousand USD (retail). Wholesale prices are lower, but our rough guidelines (not an official stat) would suggest that the cost of this drug is around 200-250USD per one vial. To place an order at the lowest price and to get the best deal, buyers must get as many offers from sellers as they can. Infliximab can be purchased from a variety of Infliximab suppliers for a variety of prices. Prices are only applicable for cash-paying customers and do not include insurance coverage. Infliximab suppliers are often supportive of patient assistance programs.

Navigating Our Pharmaceutical Marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of Infliximab offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for Infliximab manufacturers and Infliximab suppliers that you are looking for. These also enable you to check the dossier status of Infliximab, and the GMP approvals of the different variants of Infliximab. Also, each manufacturer or supplier product description contains essential information about Infliximab including clinical data, stability zones, countries where Infliximab is already registered in. Manufacturers also have special, and delivery terms.

Establishing Commercial Ties

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over Infliximab offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and order process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers or suppliers. This way, the marketplace allows you as a distributor to skip the process of making a list of product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than the Good Manufacturing Practice approvals that Infliximab manufacturers list has, we qualify their companies before they are boarded on the platform. This allows us to screen Infliximab manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.